MIRM MIRUM PHARMACEUTICALS
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 18 analyst firms say about MIRUM PHARMACEUTICALS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
16 rated views · 19 analyst/firm records · 18 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8079
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8071
Recent analyst activity · last 90 days
Our tracked history has 23 reports on MIRM from 14 analyst firms in the last 90 days (18 firms in the past year).
Comparing each firm's latest target with its previous one: 4 raised their price target, 1 lowered it, 6 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: SVB Leerink lowered its target from $154.00 (set 6 Jul 2026) to $140.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Brian Skorney | Buy | 29 Sep 2026 | 130.00 USD |
| Cantor Fitzgerald | Josh Schimmer | Buy | 29 Sep 2026 | Conflicting reports · excluded |
| Citigroup | Yigal Nochomovitz | Buy | 12 Oct 2026 | 184.00 USD |
| Citizens JMP | Jonathan Wolleben | Buy | 27 Aug 2026 | 137.00 USD |
| CLSA | Unnamed analyst | — | 15 Jun 2026 | 146.00 USD |
| Evercore ISI | Gavin Clark-Gartner | Buy | 6 Aug 2026 | 146.00 USD |
| H.C. Wainwright | Swayampakula Ramakanth | Buy | 12 Oct 2026 | 200.00 USD |
| JPMorgan | Jessica Fye | Buy | 2 Jul 2026 | 125.00 USD |
| Leerink Partners | Joseph P Schwartz | Buy | 6 Jul 2026 | 154.00 USD |
| Leerink Partners | Mani Foroohar | Buy | 26 Feb 2026 | 118.00 USD |
| Morgan Stanley | Michael Ulz | Buy | 12 Oct 2026 | 152.00 USD |
| Raymond James | Ryan Deschner | Buy | 26 Oct 2026 | — |
| RBC Capital Markets | Lisa Walter | Buy | 8 Oct 2026 | 155.00 USD |
| Stifel | James Condulis | Buy | 14 Oct 2026 | 156.00 USD |
| TD Cowen | Joseph Thome | Buy | 21 Oct 2026 | 145.00 USD |
| UBS | Unnamed analyst | — | 27 Aug 2026 | 137.00 USD |
| Weiss Ratings | Unnamed analyst | — | 22 Oct 2026 | — |
| Wolfe Research | Kalpit Patel | Buy | 19 May 2026 | Conflicting reports · excluded |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | 87.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:42 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.